Source:http://linkedlifedata.com/resource/pubmed/id/20183293
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-2-25
|
pubmed:abstractText |
To assess the anti-invasion effect of bicyclol (1) and its mechanism in human hepatocellular carcinoma (HCC) MHCC97-H cells with high metastatic potential. MTT assay was performed to evaluate the cytotoxicity of 1 to MHCC97-H cells and its inhibitory effect on the adhesion of these cells to laminin (LN) and fibronectin (FN). The anti-invasion effect of 1 was detected in an experiment using a transwell chamber. Transcription of vascular endothelial growth factor (VEGF), nm23-H1, and urokinase-type plasminogen activator receptor (uPAR) mRNAs was determined by an RT-PCR assay. The secretion and expression of alpha-fetoprotein (AFP) were analyzed by ELISA and flow cytometry, respectively. At concentrations of 10, 50, and 100 mumol/l, 1 obviously inhibited the adhesion of the MHCC97-H cells to LN and FN. The rates of inhibition of MHCC97-H cell invasion by 50 and 100 mumol/l for 1 were 37.3 and 50.2%, respectively. Drug 1 also decreased the expressions of VEGF, nm23-H1, and uPAR mRNA and the secretion of AFP in MHCC97-H cells. At low cytotoxic concentrations, the anti-hepatitis drug 1 demonstrated a significant anti-invasive effect in human HCC MHCC97-H cells with high metastatic potential. The inhibition of the expressions of VEGF, nm23-H1, and uPAR should contribute, at least in part, to the anti-invasion property of 1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/bicyclol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1477-2213
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
576-83
|
pubmed:meshHeading |
pubmed-meshheading:20183293-Biphenyl Compounds,
pubmed-meshheading:20183293-Carcinoma, Hepatocellular,
pubmed-meshheading:20183293-Cell Adhesion,
pubmed-meshheading:20183293-Hepatitis,
pubmed-meshheading:20183293-Humans,
pubmed-meshheading:20183293-Liver Neoplasms,
pubmed-meshheading:20183293-Molecular Structure,
pubmed-meshheading:20183293-Neoplasm Invasiveness,
pubmed-meshheading:20183293-Neoplasm Metastasis,
pubmed-meshheading:20183293-Sequence Homology, Nucleic Acid,
pubmed-meshheading:20183293-Tumor Cells, Cultured,
pubmed-meshheading:20183293-Urokinase-Type Plasminogen Activator,
pubmed-meshheading:20183293-Vascular Endothelial Growth Factor A,
pubmed-meshheading:20183293-alpha-Fetoproteins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanisms.
|
pubmed:affiliation |
Department of Pharmacology, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|